| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Borrelia Species DNA, Qualitative, Real-Time PCR, Miscellaneous : 15777
Test CodeLYMBLD or 15777
CPT Codes
87801
Transport Container
Preferred:
1 mL (0.5 mL minimum) whole blood collected in an EDTA (lavender-top); CSF
or synovial fluid collected in a sterile, leak-proof container.
1 mL (0.5 mL minimum) whole blood collected in an EDTA (lavender-top); CSF
or synovial fluid collected in a sterile, leak-proof container.
Transport Temperature
Refrigerated.
Specimen Stability
Blood: Ambient: 48 hours; Refrigerated: 7 days; Frozen: 30 days
CSF or Synovial fluid: Ambient: 48 hours; Refrigerated: 7 days; Frozen: 30 days
CSF or Synovial fluid: Ambient: 48 hours; Refrigerated: 7 days; Frozen: 30 days
Methodology
Real-Time Polymerase Chain Reaction
Setup Schedule
Monday - Saturday
Report Available
1-3 days (From receipt at performing laboratory)
Limitations
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range
Not detected
Clinical Significance
The diagnosis of Lyme disease is most often made by clinical examination combined with evidence of tick bite or exposure in endemic areas. Amplification of Borrelia genomic DNA from blood, fluids, or tissues can support the diagnosis.
Performing Laboratory
Quest Diagnostics
